Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Isaacs

Showing results (651-660 of 743) with videos related to

Pageof 75
Sort By:
Mutation Research|July 23, 2003
Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association studySiqun L Zheng, Josyf C Mychaleckyj, Gregory A Hawkins, et al.
Journal of the American Medical Directors Association|August 8, 2022
Emergency Department Communication in Persons Living With Dementia and Care Partners: A Scoping ReviewChristopher R Carpenter, Jesseca Leggett, Fernanda Bellolio, et al.
Annals of the Rheumatic Diseases|July 24, 2007
Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapseC H Burgoyne, S L Field, A K Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2004
Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish familiesDanielle M Friedrichsen, Janet L Stanford, Sarah D Isaacs, et al.
Cancer Research|January 2, 2009
Sequence variants at 22q13 are associated with prostate cancer riskJielin Sun, Siqun Lilly Zheng, Fredrik Wiklund, et al.
RMD Open|April 1, 2025
Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritisLeher Gumber, Fiona Rayner, Theophile Bigirumurame, et al.
Annals of the Rheumatic Diseases|May 21, 2013
Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatmentRebeccah J Mathews, James I Robinson, Michele Battellino, et al.
Annals of the New York Academy of Sciences|March 26, 2011
Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentariumBach-Yen T Nguyen, Robin D Isaacs, Hedy Teppler, et al.
Medical Care|July 6, 2021
Pragmatic Considerations in Incorporating Stakeholder Engagement Into a Palliative Care Transitions StudyClaire de Forcrand, Mara Flannery, Jeanne Cho, et al.
Annals of the Rheumatic Diseases|January 26, 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022Kevin L Winthrop, John D Isaacs, Philip J Mease, et al.
Pageof 75

Showing results (651-660 of 743) with videos related to

Sort By:
Pageof 75
Mutation Research|July 23, 2003
Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association studySiqun L Zheng, Josyf C Mychaleckyj, Gregory A Hawkins, et al.
Journal of the American Medical Directors Association|August 8, 2022
Emergency Department Communication in Persons Living With Dementia and Care Partners: A Scoping ReviewChristopher R Carpenter, Jesseca Leggett, Fernanda Bellolio, et al.
Annals of the Rheumatic Diseases|July 24, 2007
Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapseC H Burgoyne, S L Field, A K Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2004
Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish familiesDanielle M Friedrichsen, Janet L Stanford, Sarah D Isaacs, et al.
Cancer Research|January 2, 2009
Sequence variants at 22q13 are associated with prostate cancer riskJielin Sun, Siqun Lilly Zheng, Fredrik Wiklund, et al.
RMD Open|April 1, 2025
Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritisLeher Gumber, Fiona Rayner, Theophile Bigirumurame, et al.
Annals of the Rheumatic Diseases|May 21, 2013
Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatmentRebeccah J Mathews, James I Robinson, Michele Battellino, et al.
Annals of the New York Academy of Sciences|March 26, 2011
Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentariumBach-Yen T Nguyen, Robin D Isaacs, Hedy Teppler, et al.
Medical Care|July 6, 2021
Pragmatic Considerations in Incorporating Stakeholder Engagement Into a Palliative Care Transitions StudyClaire de Forcrand, Mara Flannery, Jeanne Cho, et al.
Annals of the Rheumatic Diseases|January 26, 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022Kevin L Winthrop, John D Isaacs, Philip J Mease, et al.
Pageof 75